June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
December 2025
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
July 2026
The asthma drugs market was valued at USD 26.49 billion in 2025 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
July 2026
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
July 2026
The global cephalosporin drugs market size was calculated at USD 20.65 billion in 2025 and is projected to attain around USD 27.69 billion by 2035, with a CAGR of 2.98%.
July 2026
The global diabetes drug market size was calculated at USD 75.09 billion in 2025 and is projected to hit around USD 138.83 billion by 2035 with a CAGR of 6.34%.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
July 2026
The global oxycodone drugs market size was valued at USD 7.06 billion in 2025 and is projected to reach around USD 12.10 billion by 2035 with a CAGR of 5.54%.
July 2026
The global outpatient oncology infusion market size is predicted to attain around USD 265.10 billion by 2035 from USD 96.77 billion in 2025 with a notable CAGR of 10.60%.
July 2026
The global transdermal drug delivery systems market size was evaluated at USD 78.20 billion in 2025 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
July 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2026
The global general anesthesia drugs market size was calculated at USD 5.60 billion in 2025 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
July 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
July 2026
The global 3D printed drugs market size was estimated at USD 338.28 million in 2024 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
July 2026
The global RNA interference drug delivery market size is evaluated at USD 118.18 billion in 2025 and is predicted to hit around USD 601.36 billion by 2035, growing at a CAGR of 17.67%.
July 2026
The global pharmacovigilance and drug safety software market size was evaluated at USD 2.09 billion in 2025 and is predicted to hit around USD 5.06 billion by 2035, growing at a CAGR of 9.24%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The advanced technologies in marine drug development market accelerates drug discovery with advanced tech and deep-sea pharmaceutical potential.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2026
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2026
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2026
The oncology market size surpassed USD 250.88 billion in 2025 and is expected to hit around USD 732.45 billion by 2035 with a CAGR of 11.31%.
July 2026
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com